健帆生物：第五届监事会第二十二次会议决议公告

Group 1 - The core point of the article is that Jianfan Bio announced the approval of several proposals during the 22nd meeting of its fifth supervisory board, including the proposal regarding the non-operating fund occupation and other related fund transactions for the first half of 2025 [2] Group 2 - The announcement indicates that the company is actively managing its financial operations and ensuring transparency regarding fund usage [2] - The approval of the proposals suggests a focus on compliance and governance within the company [2] - The meeting reflects the company's ongoing commitment to addressing financial matters and maintaining stakeholder trust [2]